The lymphoreticular response of dogs to Ehrlichia canis infection was studied after immunosuppressive therapy with cyclophosphamide or antilymphocyte serum. Immunosuppression did not increase mortality, nor did it prevent or significantly modify the clinical manifestations of acute ehrlichiosis. The clinical, hematologic and serum biochemical characteristics of acute ehrlichiosis appeared seven or more days later in immunosuppressed than in immunologically intact infected dogs.
Materials and Methods
Twenty purebred beagle dogs from an E. canis-free dog colony were housed, acclimated and evaluated as described [22] . The dogs were assigned randomly to one of two groups, and dogs in each group were designated as either infected (principals) or controls. The principals were infected by intravenous inoculation with whole blood from an E. canis carrier dog used as a source of inoculum in a companion experiment [22] .
Group I consisted of eight infected dogs and three uninfected controls, each of which received 50 mg of cyclophosphamide (Cytoxan, Mead Johnson Laboratories, Evansville, Ind.) per os daily beginning the day following infection of the principals. This dosage was adjusted weekly for each dog according to results of weekly hematological and clinical examinations.
Group 2 consisted of six infected dogs and three uninfected controls, each of which received subcutaneous injections of antilymphocyte serum (Equine Anti-canine Lymphocyte Serum, Microbiological Associates, Bethesda, Md.) at the dose of 1.0 ml/kg of body weight for three consecutive days pre-infection and on day I post-infection. Thereafter, the dogs received antilymphocyte serum every third day through day 42 post-infection. The dose of antilymphocyte serum for each dog was recalculated after the first week and held constant thereafter until each dog was killed. Pre-infection baseline data were handled as previously described [22) except that pre-infection samples for this group were analyzed as baseline (pre-antilymphocyte serum treatment) and post-infection day 0 (post-antilymphocyte serum day 3). Dogs in these two groups were killed and necropsied according to the schedule in table I.
Results
The clinical manifestations of acute ehrlichiosis were not changed significantly by immunosuppressive therapy. Mild to severe hematuria occurred intermittently in both infected and noninfected dogs, especially females, of group 1. Hematuria was reduced or eliminated by decreasing the dose of cyclophosphamide. Fever was found in five of eight group 1 principals on day 14 post-infection and in five of six group 2 principals on day 17, and persisted through week 5 (group 1) or week 6 (group 2). One control and one principal of group 1 died with acute bacterial infection on days 11 and 15, respectively. Principals of group 2 lost weight, but the group 2 controls gained weight during the experiment. None of the immunosuppressed dogs had detectable peripheral lymphadenomegaly, a common finding in acute ehrlichiosis.
Clinical pathology
Group 1: All of the dogs in this group developed thrombocytopenia during the second week after cyclophosphamide therapy was begun (second week after infection of principals). The same pattern of decrease, stabilization and partial recovery of circulating thrombocyte concentrations occurred in infected and noninfected dogs on cyclophosphamide therapy. Total leukocyte counts dropped precipitously in all dogs during the first week of cyclophosphamide treatment. The dosage of cyclophosphamide was reduced on day 7 post-infection and after this, the control dogs maintained concentrations of circulating leukocytes at 25% to 50% of their baseline levels. Principals had higher leukocyte counts than did the controls after day 14, and it was more difficult to maintain consistently low circulating leukocyte concentrations in the principals. Anemia of moderate severity developed, daily mean packed cell volume decreased from 46% (day 7) to 30% (day 35), and there was no evidence of an erythrogenic response in the circulating blood of infected dogs treated with cyclophosphamide. The mean serum albumin concentrations and the albumin/ globulin ratio decreased after day 14 in the principals and remained depressed throughout the remainder of the study, but were not as low as in immunocompetent principals [22] . In the controls, albumin/globulin ratios increased slightly during the last half of the experiment because the concentration of alpha-1 globulins decreased after day 21 post-infection.
Group 2: The decrease in circulating thrombocyte concentration in principals in this group did not appear until day 21 post-infection. Thrombocyte counts in controls from this group remained at or near baseline levels throughout the study. Total leukocyte concentrations remained stable in group 2 dogs because of an increase in neutrophils which largely offset a decrease in circulating lymphocytes. After remaining near pre-infection levels through day 14 post-infection, the packed cell volume decreased from a daily mean of 40% on day 14 to 24% on day 42 in the Group 2 principals. The packed cell volume remained unchanged in group 2 controls during the experiment.
The mean total serum protein concentrations increased in both the principals and controls during the pre-infection period of antilymphocyte serum treatment and the first week post-infection, but decreased in the principals after day 21 post-infection, when the mean serum albumin concentrations in the principals also decreased. A marked increase in alpha-2 globulin levels occurred in all group 2 dogs soon after treatment with antilymphocyte serum was begun. The alpha-2 globulin concentration increased from a mean of 0.56 g/dl before antilymphocyte serum to 0.97 g/dl on day 0 (three days after therapy with antilymphocyte serum was begun) to a mean of 1.03 g/dl for principals and 1.10 g/dl for controls by day 7 post-infection. The concentration of alpha-2 globulins remained elevated, with slight decrease in both principals and controls, until after day 28. No principal had an increase of more than 1.0 g/dl of total gamma globulin, and the mean serum concentration of gamma globulin in the principals did not increase during the study. Demonstrable anti-E. canis antibody existed in three antilymphocyte serum-treated principals killed on day 42 and in three of six cyclophosphamide-treated principals alive on and after day 30 (fig. 1).
Gross lesions
Gross lesions in group 1 principals were similar to those in immunocompetent principals [22] , but certain differences reflected the influence of cyclophosphamide therapy. Bacterial pneumonia, manifested by multifocal areas of consolidation associated with edema and hemorrhage, was evident in two of six principals and in one of three controls. The pneumonia had an anteroventral distribution in one principal, but was generalized in the two dogs that died on day 11 or 15 post-infection. The mean weight of the spleen in cyclophosphamide-treated principals was lower than in the immunocompetent principals [22] , and the splenic corpuscles were not as prominent. Pink to red, apparently active bone marrow was seen throughout the long bones of cyclophosphamide-treated principals. In contrast, the bone marrow was uniformly pale and fatty in the controls, regardless of the age of the dog.
Submucosal edema, mucosal and submucosal vascular engorgement, and roughened mucosa were present in the urinary bladder of every dog of group 1. Pericystic connective tissue was edematous in several dogs, but at necropsy none of the dogs had hematuria.
The three group 2 principals killed on day 2 1 did not have distinctive gross lesions. Two of the three principals killed on day 42 had multifocal anteroventral pneumonia and enlarged, slightly swollen, pale livers. All of the principals had enlarged spleens with prominent white pulp. The color and consistency of bone marrow appeared to vary with age rather than infection or antilymphocyte serum treatment (i.e., all older dogs had pale fatty marrow).
Histology
Group 1: Severe lymphoid depletion in the spleen of the control dog killed on day 12 was manifested by a sparsity of recognizable splenic corpuscles. The surviving lymphocytes in the spleen were concentratsd along trabeculae and around splenic arterioles. In the principals killed on day 12, the splenic corpuscles were more evident because of the presence of a densely packed group of small lymphocytes surrounded by a zone containing many uniform, medium-sized cells with large, open nuclei and single prominent nucleoli ( fig. 2 ). By day 30, macrophages with abundant clear cytoplasm were distributed randomly throughout the few recognizable splenic corpuscles ( fig. 3 ). The number of macrophages in each corpuscle, however, was much lower than in immunocompetent principals [22] . The number of megakaryocytes in the splenic red pulp increased markedly in all dogs by day 30.
Intrafollicular hemorrhages were present in the spleens of the principals killed on day 42, and the splenic corpuscles contained a moderate number of medium-sized lymphocytes and macrophages. There was no discernible mantle layer, but many large reticuloendothelial cells were in the perifollicular red pulp. There was mild to moderate diffuse reticuloendothelial hyperplasia in the red pulp, and a few aggregates of plasma cells were seen along trabeculae or scattered in the splenic cords. No hemorrhages or increase in the number of macrophages were seen in the splenic corpuscles of the day 42 control, but the total mass of lymphoid tissue was greatly reduced, and small aggregates of necrotic lymphocytes were present in some splenic corpuscles.
Lymph nodes from group 1 dogs killed on day 12 had few cortical follicles. The cortex and paracortex were comprised of a uniformly distributed but sparse population of small lymphocytes with no evidence of mitotic activity. The medullary cords contained plasma cells but no large lymphoid cells or mitotic figures. The cortical region of lymph nodes from one principal had a "starry-sky'' appearance because of frequent vacuolated macrophages. Lymph nodes were similar histologically in dogs killed on days 30 and 42, and lymph nodes of control dogs could not be distinguished from those of principals.
The markedly reduced number of hemopoietic cells in bone marrow from group 1 dogs made microscopic evaluation difficult. Bone marrow from the controls was essentially acellular. Hemopoietic cells persisted in the bone marrow of principals although hemopoietic hypocellularity was evident on days 30 and 42. Both the erythroid and myeloid compartments lacked cells, so the mye1oid:erythroid ratio was not abnormal except in one dog that developed granulocytosis and had an increased mye1oid:erythroid ratio on day 30. The number of megakaryocytes per low power field in hemopoietic tissue of group 1 principals increased progressively during the experiment, and was highest in those killed on day 42.
There was an increase in the number and size of Kupffer's cells, and randomly distributed aggregates of macrophages in hepatic sinusoids, in every group 1 principal except for one dog killed on day 12. Mild phlebitis and perivascular lymphoplasmacytic infiltrate associated with renal cortical stellate veins and glomeruli were found in the group 1 dogs kiled on days 30 and 42 and resembled the mildest lesions seen at day 21 in infected immunocompetent dogs [22] . Perivascular cuffs of lymphocytes and macrophages were present in the lungs of dogs killed on day 42, but the degree of interstitial thickening was not as great in cyclophosphamide-treated dogs as in immunocompetent infected dogs [22] .
There was hemorrhage and necrosis in the lamina propria of the urinary bladder of each dog killed on day 12. More severe, ulcerative lesions characterized by loss of epithelium and necrosis and edema of the underlying lamina propria were in the urinary bladder of dogs killed on day 30. By day 42 there had been an apparent attempt at healing and most of the mucosa was covered with epithelium, although the lamina propria remained inflamed and thickened. Infection with E. canis did not appear to increase the extent or severity of either the epithelial necrosis or hemorrhage in the urinary bladder.
Group 2: In two of three infected dogs killed on day 21 post-infection, the splenic corpuscles had a "starry-sky'' appearance because of the many tingible-body macrophages present. The splenic corpuscles of both principal and control dogs on day 21 contained few small lymphocytes and no evidence of hemorrhage. Many neutrophils and megakaryocytes were seen in the splenic sinuses and cords in the red pulp in both control and infected dogs, and mild, diffuse reticuloendothelial hyperplasia was evident in the red pulp of principals. The reticuloendothelial hyperplasia in the red pulp was more pronounced by day 42, and more plasma cells were seen along trabeculae and adjacent to some vessels. Small lymphocytes remained virtually absent in both controls and principals and, although splenic corpuscles were better defined, a mantle layer was not discernible (fig. 4 ).
The lymph nodes from the group 2 dogs had a thin cortex that contained both primary and secondary follicles immediately beneath the subcapsular sinus. A few small lymphocytes were in the mantle around the germinal centers, or in the narrow, inapparent paracortical area of visceral and peripheral lymph nodes ( fig. 5 ). Macrophages were unusually numerous in the paracortical area, including some with much eosinophilic cytoplasm and an epithelioid appearance. These changes occurred in lymph nodes removed from principals and control dogs alike, however, and the histologic appearance of the lymph nodes was the same in the dogs killed on days 21 and 42. Hemopoietic cellular composition of the bone marrow from the group 2 dogs resembled that of immunocompetent dogs [22] , except that the mye1oid:erythroid ratio did not become elevated until day 42. More megakaryocytes were present in the hemopoietic tissue from group 2 dogs than in other dogs, but there was no positive correlation between infection and the concentration of megakaryocytes.
Slight to moderate hepatic reticuloendothelial hyperplasia occurred, but renal lesions were minimal or absent. Pulmonary lesions were more pronounced in two of the three group 2 principals killed on day 21 than in the other antilymphocyte serumtreated principals. The lungs of these two dogs showed extensive perivascular cuffs, and many monocytes filled the lumen of most blood vessels, but no endothelial inflammatory plaques were found.
Rickettsial organisms were found in tissue imprints of lung from each principal and less frequently in tissue imprints of liver, spleen and bone marrow. Rickettsial morulae were seen only in large mononuclear cells, apparently reticuloendothelial cells or histiocytes.
Discussion
There was little difference clinically between the infected dogs of these two groups and those of the previously reported immunocompetent group (221, except that clinical signs appeared later in the dogs treated with cyclophosphamide or antilymphocyte serum (e.g., a consistent temperature elevation did not occur until three to five days later than in the untreated principals). Immunosuppressants administered in conjunction with various pathogens have been shown to modify the severity and clinical course of some diseases but to have little clinically apparent effect in others [6, 11, 211 , as was the case in this study.
Hematuria, as seen in the cyclophosphamide-treated dogs, has been associated with cyclophosphamide therapy [7, 9, 13, 231 , and the lesions found in the urinary bkdders of all of the dogs in this group resembled those reported by others in the dog [2], the rat [15, 161 , and in man [9, 131. The high serum concentrations of alpha-2 globulins in dogs treated with antilymphocyte serum probably reflected the sustained inflammatory reaction that developed in and around the sites of injection of antilymphocyte serum. Several alpha-2 globulins are associated with the acute inflammatory reaction, and significant increases in serum alpha-2 globulin concentrations may occur within eight hours after the inflammatory reaction is initiated Both of the immunosuppressants used in this study apparently diminished the synthesis of gamma globulins to the extent that hypergammaglobulinemia, a common characteristic of ehrlichiosis, failed to develop in the treated principals. Cyclophosphamide was expected to suppress the synthesis of gamma globulin because of its effect on B-cells, whereas antilymphocyte serum minimizes the humoral immune response to antigens that require helper T-cell function [12, 17, 18, 191 . Indirect fluorescent antibody titers showed that all of the dogs were uninfected immediately before the experiment was begun, and confirmed the functional immunosuppression P I f of treated dogs in these two groups. These dogs had lower, later-developing antibody titers than have been measured in immunocompetent dogs with ehrlichiosis [22, 27] .
The pattern of lymphocytic depletion in lymph nodes from group 1 dogs reflects the mitostatic and cytocidal effect of cyclophosphamide on rapidly proliferating cells [3, 7] . No mitotic activity was seen in lymph nodes from group 1 controls, and most of the cells that had persisted were small lymphocytes in the paracortical area and mature plasma cells in the medullary cords. In comparison, lymph nodes from group 1 principals were more completely depleted of lymphocytes and did not have the paracortical population of small lymphocytes found in the controls. Considering the extensive follicular and paracortical lymphoid hyperplasia in the lymph nodes of immunocompetent principals [22] , this profound depletion reflected the expected effect of cyclophosphamide on proliferating cells.
Severe depletion of the paracortical area of lymph nodes and the lymphopenia in group 2 dogs demonstrated appropriate activity of the antilymphocyte serum used in this experiment [8, 18, 191 . A decrease in the number of circulating lymphocytes, with maintenance at a low concentration, is desirable in antilymphocyte serum treatment studies [8] and was achieved in this experiment, but this parameter alone is not a reliable indicator of T-lymphocyte suppression because more short-lived lymphocytes may enter the circulation in individuals treated with antilymphocyte serum [25] . The lack of follicular response in the group 2 principals and the low gamma globulin concentrations and immunofluorescence titers in these dogs provide additional evidence that a viable active T-cell population must be present for the usual immunologic expression of E. canis infection (i.e., hypergammaglobulinemia).
The rapid development of thrombocytopenia and the lack of increase in the concentration of platelets in the blood of cyclophosphamide-treated dogs later in the experiment were attributed to the suppressive effects of this cytotoxic drug on thrombopoiesis [7] . No additional thrombocytopenic effect was attributed to E. canis infection in the cyclophosphamide-treated principals, such as would be expected if E. canis infection shortened platelet life span. To the contrary, the similar rate of decrease in circulating platelet concentrations in controls and principals suggests that lack of platelet production may be a significant mechanism by which thrombocytopenia develops in ehrlichiosis. Cyclophosphamide had an additive effect with E. canis infection on the erythron. The packed cell volume stabilized at about 30% to 32% in the group 1 principals compared with 37% to 38% in the group 1 controls and in immunocompetent principals [22] . The greatest decrease in packed cell volume, which occurred in the antilymphocyte serum-treated principals during the last half of the experiment, was not simply the result of combined effects of antilymphocyte serum and E. canis infection, because no decrease occurred in the packed cell volume of antilymphocyte serum-treated controls. The mechanism by which the anemia developed in the antilymphocyte serum-treated, infected dogs was not ascertained.
Persistence of the bone marrow hyperplasia of acute ehrlichiosis [4] in group 1 principals despite the depressive activity of cyclophosphamide is an intriguing result of this study. Increased hemopoietic activity was manifested by increased cellularity and volume of red bone marrow in the treated principals, which was in sharp contrast to the pale-yellow, hypocellular marrow of the group 1 controls. The observations suggest that E. canis infection has a stimulatory effect which, however, does not greatly increase production of mature blood cells. There is no compensatory increase or rebound above normal levels in the circulation after the initial loss of cells, but rather a new balance is established, with either a hypercellular, normocellular or hypocellular marrow present depending on the stage of the disease. Pancytopenia with hypercellular or normocellular marrow has been described by others and may result from many of the same insults associated with bone marrow hypoplasia or aplasia [20] .
It was not possible to determine quantitatively the rate of proliferation of E. canis in this study, but by at least day 21 post-infection, abundant morulae were found in antilymphocyte serum-treated principals and in fact were more prominent in this group than in immunocompetent principals. Cyclophosphamide-treated principals likewise supported E. canis replication; this finding is in keeping with reports concerning the replication of a variety of rickettsiae in cyclophosphamide-treated mice [14] .
The premise that alteration of the host's immune system would measurably alter the clinical or anatomical manifestations of experimental E. canis infection was proven valid, Infection results in hyperplasia of the lymphoreticular system in the immunocompetent host, with both the Band T-cell compartments affected during the acute stage of the disease. Selective immunosuppression showed that both the Tand B-cell compartments must be functional for the full development of histologic lesions and hypergammaglobulinemia, but that immunosuppression does not prevent the febrile response, thrombocytopenia or anemia. The pathogenicity of the organism in this study did not increase as a result of immunosuppression, implying that the immune system is not instrumental in protecting the host from E. canis. This study supports previous suppositions that the immunologic response of the dog to E. canis infection is ineffective, and suggests further that this often exaggerated response is, in fact, detrimental to the host.
